热门资讯> 正文

Aytu BioPharma 2026年第四季度盈利预览

2026-09-22 05:35

Aytu BioPharma(AYTU) 0

Aytu BioPharma (AYTU) is scheduled to announce Q4 earnings results on Monday, September 21st, after market close.
The consensus EPS Estimate is -$0.35 (+88.1% Y/Y) and the consensus Revenue Estimate is $12.28M (-18.7% Y/Y).

More on Aytu BioPharma

Seeking Alpha’s Quant Rating on Aytu BioPharma
Historical earnings data for Aytu BioPharma
Financial information for Aytu BioPharma

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。